INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 51 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $535,000 | -39.1% | 127,337 | -1.4% | 0.00% | 0.0% |
| Q3 2016 | $878,000 | +17.5% | 129,113 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $747,000 | -12.7% | 129,204 | +5.4% | 0.00% | 0.0% |
| Q1 2016 | $856,000 | +25.5% | 122,595 | +29.4% | 0.00% | 0.0% |
| Q4 2015 | $682,000 | -16.3% | 94,711 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $815,000 | -46.4% | 94,519 | +0.4% | 0.00% | -50.0% |
| Q2 2015 | $1,520,000 | – | 94,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 4,968 | $3,000 | 0.00% |
| Renaissance Technologies | 159,900 | $86,000 | 0.00% |